Market Research Report
North America Digital Genome Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||991380|
|Published||Content info||138 Pages
Delivery time: 2-3 business days
|North America Digital Genome Market Forecast 2021-2028|
|Published: March 1, 2021||Content info: 138 Pages||
The North America digital genome market is evaluated to project a CAGR of 9.60%, during the forecast years of 2021 to 2028. The high prevalence of infectious diseases, dementia, Alzheimer's disease, and cancer, the growing incidence of monogenic conditions, and the rising adoption of advanced techniques by research facilities, are among the main factors attributed to the market growth of the region.
The North America digital genome market growth is determined by assessing Canada and the United States. The surging application area of personalized medicine across Canada, is anticipated to influence the country's digital genome market. Canada's future of medicine would be data-oriented and concentrated on generating personalized medicines for individual patients, on the basis of their molecular profile. In this regard, personalized medicine, also known as molecular medicine and precision medicine, would encourage a more detailed disease diagnosis. The approach is also expected to propel therapeutic inventions, predominantly in terms of treating infectious diseases, lung ailments, cancer, heart conditions, and neurological disorders.
Likewise, personalized medicine is significant, in terms of enhancing patient care with effective treatments, leading to controlling expenses. This factor is likely to become highly crucial as patient volume continues to surge, therefore resulting in the increased importance of the digital genome market, across Canada. The Canadian Genomics Cloud is an example of a digital genome database, which entails an integrated software ecosystem for the federated sharing, analysis, and management of clinical data and genome sequence. Therefore, these factors are projected to play a crucial role in propelling the country's digital genome market over the forecast period.
Some of the key firms operating in the market are, GenomeMe, Perkin Elmer Inc, Illumina Inc, Thermo Fisher Scientific Inc, etc.